Issue 13, 2021

Water-mediated reduction of [Cu(dmp)2(CH3CN)]2+: implications of the structure of a classical complex on its activity as an anticancer drug

Abstract

The interplay between coordination geometry and reactivity in copper complexes has been widely studied for years. For CuII, it is known that the reduction is favored when the geometry is closer to that of the CuI state, which is mainly tetrahedral. Conversely, the reduction of CuII complexes in the absence of exogenous reducers has been barely addressed. Herein, we report on the ability of a classic CuII complex to be partially reduced in acetonitrile solutions containing water, in the absence of external reducers. The role of the structure on the spontaneous reduction is presented by contrasting the geometric features with a related complex, [Cu(phen)2(CH3CN)]2+, which is inert towards the redox process mediated by water. The participation of water in the reduction of [Cu(dmp)2(CH3CN)]2+ is associated with the production of hydroxyl radicals. This, prompted us to evaluate the use of [Cu(dmp)2(CH3CN)]2+ as an anticancer metallodrug, showing an activity stronger than that of [Cu(phen)2(CH3CN)]2+ on 2D and 3D models of bone, lung, and breast cancer cell lines. Furthermore, both complexes are more active than cisplatin. The main mechanism of action is the intracellular ROS generation, with a higher production of cytotoxic species by [Cu(dmp)2(CH3CN)]2+. Certainly, the performance of [Cu(dmp)2(CH3CN)]2+ as an anticancer agent and its reactivity in the solution phase are connected through the geometrical constraints imparted by the dmp ligands.

Graphical abstract: Water-mediated reduction of [Cu(dmp)2(CH3CN)]2+: implications of the structure of a classical complex on its activity as an anticancer drug

Supplementary files

Article information

Article type
Research Article
Submitted
20 Feb 2021
Accepted
05 May 2021
First published
07 May 2021

Inorg. Chem. Front., 2021,8, 3238-3252

Water-mediated reduction of [Cu(dmp)2(CH3CN)]2+: implications of the structure of a classical complex on its activity as an anticancer drug

P. Levín, M. C. Ruiz, A. I. B. Romo, O. R. Nascimento, A. L. Di Virgilio, A. G. Oliver, A. P. Ayala, I. C. N. Diógenes, I. E. León and L. Lemus, Inorg. Chem. Front., 2021, 8, 3238 DOI: 10.1039/D1QI00233C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements